JP2025518493A5 - - Google Patents

Info

Publication number
JP2025518493A5
JP2025518493A5 JP2024566539A JP2024566539A JP2025518493A5 JP 2025518493 A5 JP2025518493 A5 JP 2025518493A5 JP 2024566539 A JP2024566539 A JP 2024566539A JP 2024566539 A JP2024566539 A JP 2024566539A JP 2025518493 A5 JP2025518493 A5 JP 2025518493A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024566539A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025518493A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066819 external-priority patent/WO2023220626A2/en
Publication of JP2025518493A publication Critical patent/JP2025518493A/ja
Publication of JP2025518493A5 publication Critical patent/JP2025518493A5/ja
Pending legal-status Critical Current

Links

JP2024566539A 2022-05-13 2023-05-10 ５ｔ４結合剤及びその使用 Pending JP2025518493A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263341944P 2022-05-13 2022-05-13
US63/341,944 2022-05-13
PCT/US2023/066819 WO2023220626A2 (en) 2022-05-13 2023-05-10 5t4 binding agents and uses thereof

Publications (2)

Publication Number Publication Date
JP2025518493A JP2025518493A (ja) 2025-06-17
JP2025518493A5 true JP2025518493A5 (enExample) 2026-05-14

Family

ID=88731098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024566539A Pending JP2025518493A (ja) 2022-05-13 2023-05-10 ５ｔ４結合剤及びその使用

Country Status (16)

Country Link
US (1) US20250326858A1 (enExample)
EP (1) EP4522660A4 (enExample)
JP (1) JP2025518493A (enExample)
KR (1) KR20250024530A (enExample)
CN (2) CN120607619A (enExample)
AU (1) AU2023267764A1 (enExample)
CA (1) CA3252305A1 (enExample)
CL (2) CL2024003442A1 (enExample)
CO (1) CO2024015383A2 (enExample)
CR (1) CR20240489A (enExample)
DO (1) DOP2024000234A (enExample)
IL (1) IL316788A (enExample)
MX (1) MX2024013871A (enExample)
PE (1) PE20251275A1 (enExample)
TW (1) TW202400639A (enExample)
WO (1) WO2023220626A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025180472A1 (zh) * 2024-02-28 2025-09-04 惠和生物技术(上海)有限公司 单克隆抗体分子及其用途
US20260008868A1 (en) * 2024-07-05 2026-01-08 Solve Therapeutics, Inc. 5t4-binding proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ596295A (en) * 2006-03-10 2013-01-25 Wyeth Corp Anti-5T4 antibodies and uses thereof
CA2959694C (en) * 2014-09-04 2023-11-21 Cellectis Trophoblast glycoprotein (5t4, tpbg) specific chimeric antigen receptors for cancer immunotherapy
CN114025797A (zh) * 2019-05-31 2022-02-08 昆士兰医学研究所理事会 抗Gal9免疫抑制性结合分子

Similar Documents

Publication Publication Date Title
EP3166973B1 (en) Immune-stimulating monoclonal antibodies against human interleukin-2
JP2025163055A5 (enExample)
JP2023509448A5 (enExample)
JP2019536430A5 (enExample)
MX2010011955A (es) Inmunoglobulinas de dominio variable doble y usos de las mismas.
CN111278861A (zh) Pd-l1抗体、其抗原结合片段及医药用途
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
JP2026041845A5 (enExample)
JP2023549537A5 (enExample)
JP2025069432A5 (enExample)
JP2023540526A5 (enExample)
JP2024016024A5 (enExample)
JP2025506143A5 (enExample)
JP2023543493A5 (enExample)
JP2021528047A5 (enExample)
JP2023536631A5 (enExample)
JP2024532489A5 (enExample)
JP2021530244A5 (enExample)
JP2005528914A5 (enExample)
JP2024518776A5 (enExample)
JP2023506834A5 (enExample)
JP2025507817A5 (enExample)
JP2022521305A (ja) 抗ｐｄ－ｌ１抗体及びその使用
JP2024517953A5 (enExample)
JP2023528416A5 (enExample)